Delivery Order SPE2DB22D6029-SPE2DB24FU0MV
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML. The $4,530.60 order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This award is likely part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564097758 TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract ceiling value is $4,530.60 and has a period of performance through April 17, 2024. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML. The contract has a ceiling value of $2,265.29 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a specialty pharmaceutical product. The firm fixed price delivery order, valued at $27,183.48, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and...
- This is a $23,435.90 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML syringes, with a performance period ending on July 23, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML syringes. The delivery order is valued at $11,326.45 and has a completion date of September 25, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 contract has a completion date of February 28, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the prime...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,530.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565456335 TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medication. The contract has an ultimate completion date of September 5, 2024 and was awarded on August 14, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed-price contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,530.60 order is for the supply of TEZSPIRE 210 MG/1.91 ML SYRINGES and has a completion date of March 20, 2024. Amerisourcebergen Drug Corp's Corporate Office located in Conshohocken, Pennsylvania is the prime contractor. This order is part of Amerisourcebergen's larger...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0MVDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,195,637 units of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML SYRINGE 1.91ML. The contract, valued at $2,265.30, has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This delivery order contract is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/8/24 |